A detailed history of Cibc World Markets Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 16,952 shares of REGN stock, worth $11.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
16,952
Previous 21,616 21.58%
Holding current value
$11.7 Million
Previous $22.7 Million 21.56%
% of portfolio
0.13%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $4.78 Million - $5.61 Million
-4,664 Reduced 21.58%
16,952 $17.8 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $3.39 Million - $4.11 Million
3,834 Added 21.56%
21,616 $22.7 Million
Q1 2024

May 13, 2024

SELL
$902.69 - $993.35 $19.6 Million - $21.6 Million
-21,714 Reduced 54.98%
17,782 $17.1 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $16.5 Million - $18.8 Million
21,325 Added 117.36%
39,496 $34.7 Million
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $2.42 Million - $2.95 Million
-3,497 Reduced 16.14%
18,171 $15 Million
Q2 2023

Aug 04, 2023

BUY
$700.03 - $830.35 $10.5 Million - $12.4 Million
14,942 Added 222.15%
21,668 $15.6 Million
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $35.5 Million - $43.1 Million
-52,136 Reduced 88.57%
6,726 $5.53 Million
Q4 2022

Feb 09, 2023

BUY
$705.89 - $766.39 $40.4 Million - $43.9 Million
57,236 Added 3520.05%
58,862 $42.5 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $6.85 Million - $8.65 Million
-11,941 Reduced 88.02%
1,626 $1.12 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $6.29 Million - $8.48 Million
-11,478 Reduced 45.83%
13,567 $8.02 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $1.66 Million - $1.95 Million
2,794 Added 12.56%
25,045 $17.5 Million
Q4 2021

Feb 11, 2022

SELL
$543.48 - $670.97 $3.05 Million - $3.76 Million
-5,608 Reduced 20.13%
22,251 $14.1 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $11.2 Million - $13.2 Million
19,456 Added 231.54%
27,859 $16.9 Million
Q2 2021

Aug 10, 2021

SELL
$472.8 - $558.54 $2.68 Million - $3.16 Million
-5,662 Reduced 40.26%
8,403 $4.69 Million
Q1 2021

May 07, 2021

SELL
$446.73 - $548.2 $6.54 Million - $8.02 Million
-14,630 Reduced 50.98%
14,065 $6.66 Million
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $872,419 - $1.11 Million
1,824 Added 6.79%
28,695 $13.9 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $5.69 Million - $6.87 Million
10,437 Added 63.51%
26,871 $15 Million
Q2 2020

Aug 12, 2020

BUY
$493.32 - $643.92 $822,364 - $1.07 Million
1,667 Added 11.29%
16,434 $10.2 Million
Q1 2020

May 12, 2020

SELL
$336.18 - $494.43 $9.74 Million - $14.3 Million
-28,986 Reduced 66.25%
14,767 $7.21 Million
Q4 2019

Feb 13, 2020

BUY
$274.13 - $376.51 $3.06 Million - $4.2 Million
11,167 Added 34.27%
43,753 $16.4 Million
Q3 2019

Nov 12, 2019

SELL
$273.46 - $318.39 $16.5 Million - $19.2 Million
-60,384 Reduced 64.95%
32,586 $9.04 Million
Q2 2019

Aug 13, 2019

BUY
$299.6 - $414.82 $13.2 Million - $18.3 Million
44,208 Added 90.66%
92,970 $29.1 Million
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $8.49 Million - $10 Million
22,820 Added 87.97%
48,762 $20 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $655,856 - $787,137
1,953 Added 8.14%
25,942 $9.69 Million
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $2.39 Million - $2.78 Million
6,800 Added 39.56%
23,989 $9.69 Million
Q2 2018

Aug 13, 2018

BUY
$284.6 - $344.99 $817,371 - $990,811
2,872 Added 20.06%
17,189 $5.93 Million
Q1 2018

May 11, 2018

SELL
$315.82 - $393.78 $4.06 Million - $5.07 Million
-12,863 Reduced 47.33%
14,317 $4.93 Million
Q4 2017

Feb 13, 2018

SELL
$358.63 - $469.95 $13.5 Million - $17.7 Million
-37,678 Reduced 58.09%
27,180 $10.2 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $28 Million - $32.7 Million
64,858
64,858 $29 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $73.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.